200 related articles for article (PubMed ID: 1609156)
1. Malignant mesothelioma: cytologic diagnosis with histologic, immunohistochemical, and ultrastructural correlation.
Leong AS; Stevens MW; Mukherjee TM
Semin Diagn Pathol; 1992 May; 9(2):141-50. PubMed ID: 1609156
[TBL] [Abstract][Full Text] [Related]
2. Long microvilli of mesothelioma are conspicuous in pleural effusions processed by Ultrafast Papanicolaou stain.
Yang GC
Cancer; 2003 Feb; 99(1):17-22. PubMed ID: 12589641
[TBL] [Abstract][Full Text] [Related]
3. Mucin-positive epithelial mesothelioma.
MacDougall DB; Wang SE; Zidar BL
Arch Pathol Lab Med; 1992 Aug; 116(8):874-80. PubMed ID: 1341882
[TBL] [Abstract][Full Text] [Related]
4. Cytopathologic differential diagnosis of malignant mesothelioma, adenocarcinoma and reactive mesothelial cells: A logistic regression analysis.
Cakir E; Demirag F; Aydin M; Unsal E
Diagn Cytopathol; 2009 Jan; 37(1):4-10. PubMed ID: 18973123
[TBL] [Abstract][Full Text] [Related]
5. Differential diagnosis between mesothelioma and adenocarcinoma: a multimodal approach based on ultrastructure and immunocytochemistry.
Bedrossian CW; Bonsib S; Moran C
Semin Diagn Pathol; 1992 May; 9(2):124-40. PubMed ID: 1609155
[TBL] [Abstract][Full Text] [Related]
6. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
Ylagan LR; Zhai J
Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructure of pleural mesothelioma and pulmonary adenocarcinoma in malignant effusions as compared with reactive mesothelial cells.
Sakuma N; Kamei T; Ishihara T
Acta Cytol; 1999; 43(5):777-85. PubMed ID: 10518130
[TBL] [Abstract][Full Text] [Related]
8. The distinction of mesothelioma from adenocarcinoma in malignant effusions by electron microscopy.
Kobzik L; Antman KH; Warhol MJ
Acta Cytol; 1985; 29(3):219-25. PubMed ID: 3859121
[TBL] [Abstract][Full Text] [Related]
9. Contact between abluminal microvilli and collagen fibrils in metastatic adenocarcinoma and mesothelioma.
Carstens PH
J Pathol; 1992 Feb; 166(2):179-82. PubMed ID: 1560319
[TBL] [Abstract][Full Text] [Related]
10. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
Friedman MT; Gentile P; Tarectecan A; Fuchs A
Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
[TBL] [Abstract][Full Text] [Related]
11. Ultrastructurally "invasive" microvilli in an aggressively metastasizing biphasic malignant mesothelioma.
Zu Y; Sidhu GS; Wieczorek R; Cassai ND
Ultrastruct Pathol; 2002; 26(6):403-9. PubMed ID: 12537765
[TBL] [Abstract][Full Text] [Related]
12. Pleural mesothelioma of epithelial type and pulmonary adenocarcinoma: an ultrastructural and cytochemical comparison.
Dewar A; Valente M; Ring NP; Corrin B
J Pathol; 1987 Aug; 152(4):309-16. PubMed ID: 3668733
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of calretinin immunohistochemistry in cytologic cell block preparations.
Wieczorek TJ; Krane JF
Cancer; 2000 Oct; 90(5):312-9. PubMed ID: 11038429
[TBL] [Abstract][Full Text] [Related]
14. Macroscopic, histologic, histochemical, immunohistochemical, and ultrastructural features of mesothelioma.
Hammar SP
Ultrastruct Pathol; 2006; 30(1):3-17. PubMed ID: 16517466
[TBL] [Abstract][Full Text] [Related]
15. The cytologic diagnosis of mesothelioma.
Ehya H
Semin Diagn Pathol; 1986 Aug; 3(3):196-203. PubMed ID: 3616223
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic significance of carcinoembryonic antigen in the differential diagnosis of malignant mesothelioma.
Mezger J; Lamerz R; Permanetter W
J Thorac Cardiovasc Surg; 1990 Dec; 100(6):860-6. PubMed ID: 2147220
[TBL] [Abstract][Full Text] [Related]
17. Malignant mesothelioma: ultrastructural distinction from adenocarcinoma.
Warhol MJ; Hickey WF; Corson JM
Am J Surg Pathol; 1982 Jun; 6(4):307-14. PubMed ID: 6287872
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructural studies of cells in body cavity effusions.
Bewtra C; Greer KP
Acta Cytol; 1985; 29(3):226-38. PubMed ID: 3859122
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical differentiation of malignant mesothelioma, mesothelial hyperplasia and metastatic adenocarcinoma in serous effusions, utilizing staining for carcinoembryonic antigen, keratin and vimentin.
Duggan MA; Masters CB; Alexander F
Acta Cytol; 1987; 31(6):807-14. PubMed ID: 2447718
[TBL] [Abstract][Full Text] [Related]
20. My approach to the diagnosis of mesothelial lesions.
Butnor KJ
J Clin Pathol; 2006 Jun; 59(6):564-74. PubMed ID: 16731600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]